lisdexamfetamine:

Chen Jian-Min1, Wang Zhi-Yuan2, Liu Ke2

  • 1Beijing Key Laboratory of Neuropsychopharmacology, State Key Laboratory of Toxicology and Medical Countermeasures, Beijing Institute of Pharmacology and Toxicology, 27th Taiping Road, Beijing 100850, China; Department of Pharmacy, Nanxishan Hospital of Guangxi Zhuang Autonomous Region, 46th Chongxin Road, Guilin 541000, China.

Experimental neurology
|February 9, 2024
PubMed
概括

利斯美胺 (Lisdexamfetamine) 比d-anfetamine更有效地增强工作记忆和注意力等执行功能,副作用较少. 这是由于其稳定释放的安非他胺和独特的神经化学特征,特别是在中间前额叶皮层.